Pique Therapeutics Inc.
This article was originally published in Start Up
Executive Summary
Many attempts to develop therapeutic cancer vaccines have focused on boosting immune system response to vanquish naturally immunogenic tumors. Pique Therapeutics is instead creating vaccines against non-immunogenic tumors, which since they don't stimulate the immune system, have never developed a way to evade it. Pique reasons that if those tumors can be made visible to the immune system, they will prove more susceptible to being overcome than tumors that are accustomed to fighting.